TVGN Stock Analysis: Buy, Sell, or Hold?
TVGN - Tevogen Bio Holdings Inc. Common Stock
$0.28
-0.02 (-5.39%)
▼
5d:
-17.2%
30d:
-22.84%
90d:
-55.3%
HOLD
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Mar 31, 2026
Get Alerted When TVGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TVGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TVGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TVGN is currently trading at $0.28, which is considered oversold relative to its 30-day fair value range of $0.31 to $0.37.
Technical Outlook: Technically, TVGN is in a strong downtrend. The price is currently testing key support at $0.28. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: TVGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+1681.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TVGN is in a strong downtrend. The price is currently testing key support at $0.28. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: TVGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+1681.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.31 -
$0.37
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BULLISH: Trading 1681.3% below Wall St target ($5.00)
- CAUTION: 5-day price weakness (-17.2%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.31 -
$0.37
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.28
Resistance Level
$0.37
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.28
Wall Street Target
$5.00
(+1681.3%)
Last updated: February 03, 2026 7:09 PM ET
Data refreshes hourly during market hours. Next update: 8:09 PM
Data refreshes hourly during market hours. Next update: 8:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TVGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 57 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 60 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 62 BUY |
